Virtual Invest Meetup, Silicon Valley,
November 5, 2020.

Share with Friends:
Ticket Information

Huge investments towards the development of projects related to the wholesome, life extension ideologies, as well as anti-aging technologies.

Biohacking, BioTech, HealthTech, DigitalHealth is not just a fashion trend. It is the way to the future.

 

One of the purposes of Unicorn Lab is promoting beneficial cooperation and partnership between entrepreneurs and investors from the Industry.

 

We invite you to join our Virtual Invest Meetup in Silicon Valley. It is the networking event where top tear Investors from HealthTech and BioTech industries meet innovation Startups working to promote Longevity and Health spans.

 

Date and time: November 5, 10 am - 1 pm PT.

 

It is a great opportunity to:

- Learn from Industry Experts and gain life-changing knowledge and insight.

- Find Innovative Solutions and Technologies for your investment portfolio.

 

The Meetup will start with the Panel Discussion "Impact Investment in innovation Startups working to promote Longevity and Health spans".

Experienced and renowned Venture Capital Investors will describe the topic from their perspectives.

 

The second part will be dedicated to the Presentations of selected HealthTech, LongevityTech, and BioTech Startups.

Each entrepreneur will have 10 minutes for their Pitch which will be followed by a Q&A session with invited VCs.

 

If you are interested in presenting your Startup at the Meetup, please Apply and we will get back to you with a feedback http://bit.ly/ApplyStartupBC

 

Join us as a Guest!

We are looking forward to meeting you!

Speakers
x
Safa Rashtchy
Founder and Managing Partner at Think + Ventures

Safa Rashtchy is the founder and Managing Partner of Think + Ventures, a thesis-based and research-driven early-stage fund in Silicon Valley. Safa has been a Silicon Valley investor, advisors, and board member for over 12 years and has invested in over 60 companies. His investments include Bina Technologies (acquired by Roach), Tubi.tv (acquired by Fox Media), Nimble VR (acquired by Facebook), and several other exists.

Safa is an advisor/board observer to Snapwire, Spry Health, Axgen, and Contilio. His thesis on consumer value proposition and market-driven investments have been at the core of Think + Ventures. Safa pioneered the concept of “Teen Focus Groups” for internet and online trends and has continued his mission to encourage companies to get close to their customer and to listen to them.

Safa has worked with and advised numerous public companies during his Wall Street years, including Google, Alibaba, Netflix, Yahoo, and others. From 1997 until 2007, Safa was a Managing Director at Piper Jaffray and Company. He led the firm’s expansion efforts in the Internet industry and its expansion to China, as well as active involvement with leading Internet and technology companies.

Safa enjoyed top ranking and recognition from Wall Street, including three consecutive years of the prestigious Institutional Investor (II) ranking, as well as top rankings for stock picks and earnings estimates. In 2007, Safa was named the Investment Analyst of the Year and received the 2007 New Economy Award from iResearch in China. In 2002, Safa was named to The Wall Street Journal’s ”Best on the Street” analyst survey and was also a winner in Institutional Investor magazine’s “Home Run Hitters of 2001″ top stock pickers list.

Safa holds a Master’s degree in business administration, summa cum laude, from Boston University, and a Bachelor’s degree in engineering from Purdue University.

 

Lu Zhang
Founder & Managing Partner, Fusion Fund

Lu Zhang is the Founder and Managing Partner of Fusion Fund, a renowned Silicon Valley based investor, a serial entrepreneur, and a Stanford Engineering alumna. Fusion Fund is active in supporting early-stage entrepreneurs who are looking to build globally disruptive companies using innovative technologies to drive systemic change originating from the U.S market. For the past couple of years, Lu leads the Fusion Fund team funnels exits of multiple portfolios’ IPO and M&As.

Lu received the title of 2018 Young Global Leader by the World Economic Forum (Davos). She has also garnered other accolades including the Featured Honoree in VC of Forbes 30 Under 30 (2017), Silicon Valley Women of Influence (2018), Town & Country 50 Modern Swans – Entrepreneurship Influencer (2017), and Top 10 All America Chinese Youth (2018). Prior to starting Fusion Fund, Lu was the Founder and CEO of a medical device company focused on non-invasive technology for the early diagnosis of Type II diabetes (acquired in 2012). 

Lu is active in the entrepreneur and investor communities and serves as a board member and 2020 president for Youth Council of Future Forum.

Po Bronson
Managing Director of IndieBio

Po is Managing Director of IndieBio.

Po was a finance and tech journalist covering Silicon Valley for Wired, The New York Times Magazine, and an oped contributor for The Wall Street Journal.

His science journalism has been honored with nine national awards, and he is the author of seven bestselling books that are available in 28 languages worldwide. His work has been cited in 185 academic journals and 503 books. His background is in Economics with specialization in understanding firm behavior in collaborative networks. He learned finance at Credit Suisse and consulting at a division of Arthur Andersen. Prior to IndieBio he spent four years as a Futurist with Attention Span Media, consulting corporate innovation efforts for globally-recognized brands.

Most recently, Po is the author of Decoding the World: A Roadmap for the Questioner, published by Twelve Books, a division of the Hachette Publishing Group.

Brian Mac Mahon
Founder, Expert DOJO

Brian Mac Mahon is a serial entrepreneur as well as the most active and aggressive startup investor in Southern California who has owned companies in over 35 countries. He is also the owner of Expert DOJO, the largest International early-stage startup accelerator in Santa Monica. Brian specializes in helping entrepreneurs to become more successful in their businesses by using all the tools available to him as the owner of the largest peer to peer peak performance academy in the world.

Brian is committed to investing in founders from all backgrounds and industries based on the merit of the execution of their value proposition only. In 2018 & 2019, he brought 400 companies through his startup accelerator program and made a total of 42 investments. During the Covid-19 crisis and after, he intends to make more startup investments and help more entrepreneurs from all over the world push forward and succeed.

Julia Smila
Co-Founder, Unicorn Lab & Biohacking Congress

Julia is passionate about Entrepreneurship and Biohacking. 

She has been working for the Venture Capital Industry for more than 5 years, and she is experienced in investor relationship management and startup operations. 

As Event Director she has held more than 150 Startups Conferences in the US and all over the world and has got a wide global network of VCs and CVCs. 

Julia is the Co-organiser of Biohacking Congress, the international platform dedicated to furthering the advancement of Biohacking, Longevity, Wellness, BioTech, DigitalHealth.

Kate Batz
Managing Partner, Longevity Capital

Kate is a Managing Partner at Longevity Capital as well as a Director of Strategy and Business Development at Deep Knowledge Ventures, Aging Analytics Agency and Deep Knowledge Analytics. She is an experienced corporate attorney by background, licensed to practice law in California (2003), New York (2004) and Russia (2000), with an extensive sales and marketing experience.

Compelled by the paradigm-shifting advances in science and technology in the fields of aging and longevity, Kate enthusiastically joined Deep Knowledge Ventures Group. 

 

Safa Rashtchy
Founder and Managing Partner at Think + Ventures
Lu Zhang
Founder & Managing Partner, Fusion Fund
Po Bronson
Managing Director of IndieBio
Brian Mac Mahon
Founder, Expert DOJO
Julia Smila
Co-Founder, Unicorn Lab & Biohacking Congress
Kate Batz
Managing Partner, Longevity Capital
Investors
x
Dr. Yi-Yen Chen
Principal at WI Harper

Dr. Yi-Yen Chen has over 9 years of healthcare-related experience. Currently, she is responsible for US healthcare investment and portfolio management at WI Harper. Prior to joining the Healthcare Investment Team, she worked in business development and drug licensing at Microbio Group in Taiwan. Dr. Chen was the R&D project head and led the development of the world’s biggest antibody portfolio for the zebrafish research community at GeneTex.

She completed her PhD in developmental biology from Nobel Laureate Professor Christiane Nüsslein-Volhard’s lab at the Max-Planck Institute in Germany. Her postdoctoral training was in molecular biology at the Institute of Molecular Biology in Mainz, Germany, and in cancer immunotherapy at the Netherlands Cancer Institute in Amsterdam.

Widya Mulyasasmita
Vice President at Red Tree VC

Widya Mulyasasmita, Ph.D. is Vice President at Red Tree VC, a venture capital firm investing in life sciences innovation. In addition to investing, Widya specializes in launching and leading business development in early-stage life sciences companies. She served as Acting Chief Business Officer at xCella Biosciences, an antibody discovery company. Prior to xCella, Widya was the Chief Business Officer and a Founding Team member at InterVenn Biosciences (a cancer liquid biopsy company) where she led partnership strategy and business operations. Widya was previously Director of New Ventures at Johnson & Johnson Innovation, sourcing and managing partnership deals across the medical device and pharmaceutical sectors on the US West Coast and Australia. She came to J&J from McKinsey & Company, where she was a management consultant advising clients in healthcare and other industries on corporate strategy, lean operations and organizational health topics. Widya received her B.S. in Materials Science and Bioengineering from the University of California Berkeley where she was awarded the Bioengineering Departmental Citation, and her Ph.D. in Bioengineering from Stanford University where she was a Siebel Scholar.

Tim Safin
Associate at Longevity Vision Fund

Tim Safin is an investment professional with a primary focus on biotechnology venture capital with over 5 years of Strategy Consulting experience supporting Big Pharma and Biotechnology companies in organic business growth, M&A and transformation. Tim is experienced in VC and public companies investments focusing on advanced therapeutics, diagnostics, and medical devices.

Tim is an Associate at Longevity Vision Fund. LVF is a $100m Venture Capital Fund that invests in early diagnostics, AI in healthcare, and therapies addressing age-related diseases.

Dr. Ella Li
Partner of ZGC Innovation fund

Dr. Ella Li is the partner of ZGC Innovation fund, and also serves as the VP of ZGC Capital Corporation in Silicon Valley leading ZGC’s team in investment and incubator operation. Dr. Ella Li has 15+ years of experience in pharmaceutical and biotechnology sectors and has rich investment experiences in therapeutic investment opportunities. She has also rich experiences in digital health, AI and IOT sectors, and serves as a board advisor, consultant and mentor for many global accelerators, incubators and VCs.

Dr. Ella Li earned her B.S. and M.S. degrees from Peking University School of Pharmacy, and her Ph.D. from the University of Texas Health Science Centers. She completed her postdoctoral fellowship from Harvard Medical School, where she led five independent projects exploring novel therapeutic targets for metabolic disease. Ella has extensive publications in prestigious journals with IMF over 10 including Nature Communication, Cell Metabolism, Journal of Clinical Investigation, PNAS, Molecular Cell, Diabetes, etc. with 500+ citations.

Gwen Cheni
Venture Partner, Fusion Fund

Gwen Cheni is currently a Venture Partner at Fusion Fund, an early-stage venture fund in Palo Alto, and an Entrepreneur in Residence at Singularity University Ventures. Prior to venture, Gwen was the Assistant Portfolio Manager at a technology-focused hedge fund in San Francisco. Gwen spent eighteen years as a public equities analyst and portfolio manager, and started her career as an Analyst at Goldman Sachs and an Associate at JPMorgan. She has been angel investing since 2012, a frequent speaker and judge at startup pitch contests.

Yuan-Ping Huang
Investment Manager, Applied Ventures

Yuan-Ping (YP) Huang is an Investment Manager at Applied Ventures where he focuses on the intersection of Life Sciences and semiconductor manufacturing. He aspires to help accelerate development of next-generation diagnostic and research tools as well as novel therapeutic modalities by bridging capabilities of Applied Materials and emerging biotechnologies from portfolio companies.

 

Prior to joining Applied Ventures, YP was an early member of Lam Capital, where he built comprehensive proteomics product strategy and led investments in molecular profiling space. He also worked as an associate at McKinsey & Company, where he advised global pharmaceutical clients on R&D and operations.

 

YP holds a Ph.D. in Biomedical Sciences from Columbia University as well as an M.S. degree in Molecular Medicine and a B.S. degree in Zoology from National Taiwan University.

David Cao
Management Partners, F50 Ventures

David is a pioneer and passionate leader of the venture capital ecosystem in Silicon Valley. David founded Silicon Valley’s largest entrepreneur community SVE. He founded several large developer communities including Silicon Valley Developer Network (SVDN), Silicon Valley Android Developers. He is also serving or served as an advisor for DocuSign, Ehouse Capital, Peakview’s Fund of Fund. He hosted interviews with leaders in the venture ecosystem for SVE.io David Cao was the Founder & CEO of GWC US (Sold to holding company); the founding president of the Silicon Valley Entrepreneur Toastmaster Club; founder and CEO of ExtendLogic (Acquired by BeyondSoft). Prior, he was the VP of Engineering at PlayPhone (Acquired by Gungho), a leading mobile entertainment in the USA, and Engineering lead for LightSurf, acquired by VeriSign for 274M USD. He has consulted for many firms including Oracle, ETravel, IBM Global Services, Sun Microsystems, OCBC Bank, and Reuters Asia.

Jacqueline Berardo
VC, Rosecliff Ventures
Irina Lanina
Venture Partner, VU Venture Partners

Irina is a Venture Partner focusing on Healthcare at VU Venture Partners, a global venture fund with offices in San Francisco, New York and Hongkong. Prior to VC, she enjoyed a 15 years career in technical and commercial roles in Medical Devices and Pharma in Germany and the US. Furthermore, Irina pursues angel investments. She is a Biomedical Engineer, holds a Masters in Business and is fluent in Russian, German and English.

Adam Dakin
Managing Director, Dreamit Ventures

Adam serves as the Managing Director for Dreamit Ventures where he leads the HealthTech vertical.  Dreamit focuses on late seed and Series A digital health and medtech companies. His career has focused on building early stage venture-backed healthtech companies.  He co-founded five health technology companies which have collectively raised over $60M in early stage capital.  Adam serves on the boards of Safkan Health, RightAir Medical, and ZSX Medical, and is an active angel investor. He is a named inventor on seven U.S. patents.  Adam holds a BSE from the Wharton School and an MBA from UCLA. 

Max Zamkow
Partner, Third Act Ventures

Max is the Founding Partner of Third Act Ventures, a seed-stage Venture Capital firm investing specifically in Agetech. Max started his entrepreneurial career while earning a BS & MS in Bioinformatics from Stanford University and before moving to the other side of the table was an integral part of Mobclix (acquired by Velti), NoiseToys (acquired by Jawbone), and Fav.tv (acquired by TVGuide.com). Max is known for monthly Agetech newsletters, co-leading Aging2.0 New York, and for successfully pitching DCM during a blackout. With a singular focus on Agetech, Third Act Ventures is able to empower visionary entrepreneurs to accelerate the pace of innovation.

Dr. Yi-Yen Chen
Principal at WI Harper
Widya Mulyasasmita
Vice President at Red Tree VC
Tim Safin
Associate at Longevity Vision Fund
Dr. Ella Li
Partner of ZGC Innovation fund
Gwen Cheni
Venture Partner, Fusion Fund
Yuan-Ping Huang
Investment Manager, Applied Ventures
David Cao
Management Partners, F50 Ventures
Jacqueline Berardo
VC, Rosecliff Ventures
Irina Lanina
Venture Partner, VU Venture Partners
Adam Dakin
Managing Director, Dreamit Ventures
Max Zamkow
Partner, Third Act Ventures
Funds
Think + Ventures, LLP
Fusion Fund
WI Harper Group
IndieBio
Red Tree Venture Capital
Longevity Vision Fund
ZGC Innovation Fund
Expert DOJO
Applied Ventures
F50
VU Venture Partners
Rosecliff Ventures
Longevity Capital
Dreamit Ventures
Third Act Ventures
F50 Elevate
Testimonials
Siim Land
Founder, Body Mind Empowerment

 

The BiohackingCongress brings together groups of people who otherwise wouldn't meet and helps to overcome boundaries between health, business, and science.

Kaspars Vendelis
Co-Founder, Biohacking.lv

 

BiohackingCongress in London gathered all the European most influential biohackers, experts, and leaders in one place. To share ideas, insights, and trends. The event was valuable for its speakers’ content. But almost underappreciated is the communications and networking part in non-formal conversations during the breaks. So many valuable topics and themes were discussed before and after the official part. Two thumbs up!

Vasily Nikolaev
Unicorn Lab
Fundraising Advisor

 

I know the team from Biohacking Congress for a long time; they are top-level professionals with tons of experience, connections, and lots of energy to provide superior service to their clients. They are particularly strong in helping companies in their Business Development activities in the USA and have a very strong network of investors here.

Nikolina Lauc
GlycanAge
Co-Founder & CEO, GlycanAge

 

Great team with amazing energy. Really supportive, I pitched at their event, they helped prepare me with some training session and great mentors. Thank you, BiohackingCongress!

Sarah Turner
Recharge
Science Manager, Recharge

 

Thank's to Julia and the team at the BiohackingCongress for a great event. The Recharge team had a great time showing the FlexBeam, presenting on red light therapy and meeting all the top speakers and biohackers - we are looking forward to the next event - very well organized and a lot compacted into one day. Inspiring!

Wesley King
Coherent Capital
Biohacking Investment Banker

 

It was a pleasure being at such a well hosted and run event! I go to so many startup pitch events, and this was one of my favorites. Informative and engaging throughout, and the investors asked fantastic questions.